Breaking Stories

The Wall Street Journal: Novavax delays its COVID-19 vaccine timeline


Novavax Inc. has delayed plans to seek regulatory clearances for its COVID-19 vaccine, while shortages in raw materials are slowing the ramp-up of production of doses, the company said.

Earnings Results: Wynn to take online-gambling arm public with help of a SPAC

Previous article

: Will the Colonial Pipeline outage hike gas prices? It all depends on where you live

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *